Cancer Clinical Trials

Biomarkers in Samples From Patients With Endometrial Cancer

This research study is studying biomarkers in samples from patients with endometrial cancer. Studying samples from patients with cancer in the laboratory may help doctors learn mor

Study number:: NCT01199250

Cohorts:: 1

Study phase:: N/A

Overall status:: Recruiting

Study type:: Any

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

This research study is studying biomarkers in blood and tissue samples from patients with uterine cancer. Studying samples of blood and tissue from patients with cancer in the labo

Study number:: NCT01344837

Cohorts:: 1

Study phase:: N/A

Overall status:: Not yet recruiting

Study type:: Any

Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

This research study is studying biomarkers in tissue samples from patients with stage III, stage IV, or recurrent endometrial cancer. Studying samples of tumor tissue from patients

Study number:: NCT01164735

Cohorts:: 1

Study phase:: N/A

Overall status:: Recruiting

Study type:: Any

Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer

This clinical study will use the small molecule translocator protein (TSPO) ligand, 18F-labeled DPA- 714, to visualize and quantify neuroinflammation in treatment naivete women wit

Study number:: NCT04542603

Cohorts:: 1

Study phase:: 1

Overall status:: Recruiting

Study type:: Targeted therapy

Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)

This clinical study will investigate the utility of Fludeoxyglucose (18F) fluoromisonidazole (FMISO), in patients diagnosed with triple negative breast cancer (stage II-IV disease)

Study number:: NCT04861077

Cohorts:: 1

Study phase:: 1

Overall status:: Recruiting

Study type:: Any

Astrazeneca

Key trial

Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer

Cadonilimab, a PD-1/CTLA-4 bi-specific antibody, is being developed by Akeso, Inc. for the treatment of a range of solid tumors, including cervical cancer, lung cancer, gastric/gas

Study number:: NCT06140589

Cohorts:: 1

Study phase:: N/A

Overall status:: Recruiting

Study type:: Any

Assessing Clinical Trial Experiences of Patients With Osteosarcoma

Clinical study participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a var

Study number:: NCT05535283

Cohorts:: 1

Study phase:: N/A

Overall status:: Recruiting

Study type:: Any

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

Clinical studies with a distinct emphasis on mantle cell lymphoma play a pivotal role in evaluating the safety and effectiveness of novel treatments for this disease. These trials

Study number:: NCT06049472

Cohorts:: 1

Study phase:: N/A

Overall status:: Recruiting

Study type:: Any

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

This is a prospective, single-arm, open-label, non-interventional, multicenter, post-marketing surveillance to assess the safety and effectiveness of Zirabev(Bevacizumab biosimilar

Study number:: NCT04889495

Cohorts:: 1

Study phase:: N/A

Overall status:: Not yet recruiting

Study type:: Any

A Study to Learn More About How Well Sevabertinib (BAY 2927088) Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called human epidermal growth factor rec

Study number:: NCT06452277

Cohorts:: 1

Study phase:: 3

Overall status:: Recruiting

Study type:: Targeted therapy